Article metrics

PDF
AB0629 Design of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial of The Toll-like Receptor Antagonist IMO-8400 in Patients with Dermatomyositis

Statistics from Altmetric.com

Online download statistics by month:

AbstractPDF
Jul 201640
Aug 201682
Sep 2016103
Oct 201610
Nov 2016142
Dec 2016100
Jan 201780
Feb 201770
Mar 2017111
Apr 201791
May 2017145
Jun 201770
Jul 201760
Aug 2017100
Total11914